The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024
This Order prohibits, subject to exceptions, the retail sale, and the supply in circumstances corresponding to retail sale, of medicinal products that consist of or contain a list of gonadotrophin-releasing hormone (“GnRH”) analogues (article 4). It is the fourth such Order – and is made in effectively the same terms as the temporary Order which preceded it, the Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024 (S.I. 2024/1110), which expires immediately before this Order comes into force.
Sign in to trackLast fetched 03 May 2026 · legislation.gov.uk
Lifecycle
Department
Made
11 Dec 2024
—
In force
01 Jan 2025
Enabling power
Where the consulted organisations availed themselves of the opportunity of being heard, or after considering the representations of the consulted organisations, as the case may be, the Commission reported their findings and conclusions to the Ministers and the Ministers took that report into account in determining whether to make the Order. In accordance with section 129(7) of that Act, the Ministers also took the advice of the Commission into account before proceeding with their proposals.
DocumentsOpen on legislation.gov.uk →